New Market Research Report: Spain Pharmaceuticals & Healthcare Report Q4 2013
We expect pressures on the French government to mount over the coming quarters encouraging it to engage in more concerted fiscal consolidation, particularly as lower growth begins to translate into lower government revenues. We believe that the pharmaceuticals and healthcare sector, which is a recipient of a large proportion of public funds, will be a target of the government's cost containment efforts. While France has not fallen prey to the bond vigilantes thus far, unlike the peripheral countries of the...
View full press release